Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.050
-0.040 (-3.67%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Virax Biolabs Group Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Virax Biolabs Group stock has a target of 3.00, which predicts an increase of 185.71% from the current stock price of 1.05.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Virax Biolabs Group is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 |
|---|---|
| Strong Buy | 1 |
| Buy | 0 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +185.71% | Mar 31, 2025 |
Financial Forecast
Revenue This Year
8.24M
from 156.42K
Increased by 5,169.18%
Revenue Next Year
13.76M
from 8.24M
Increased by 66.97%
EPS This Year
-0.06
from -3.36
EPS Next Year
0.04
from -0.06
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.5M | 14.2M | 4.2M | |||
| Avg | 8.2M | 13.8M | 4.1M | |||
| Low | 7.9M | 13.2M | 3.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5,323.9% | 71.9% | -69.5% | |||
| Avg | 5,169.2% | 67.0% | -70.4% | |||
| Low | 4,962.0% | 60.4% | -71.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.06 | 0.04 |
| Avg | -0.06 | 0.04 |
| Low | -0.06 | 0.04 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.